Table 2 Prognoses of differentiated thyroid carcinomas resected for cure (R0)- overall observed 5-year survival rates 1990–1999 stratified by tumour size (253 cases; exclude 6 anaplastic carcinomas).
From: Thyroid cancer in Luxembourg: a national population-based data report (1983–1999)
Observed 5-year survival rates R0 | |||
|---|---|---|---|
pT1 (0.1–0.9 cm) | n = 172 cases | 97.1%* | (168/172) |
0.1–0.4 cm | n = 52 cases | 98.1%* | (51/52) |
0.5–0.9 cm | n = 57 cases | 100% | (57/57) |
1.0–1.4 cm | n = 38 cases | 97.4%* | (37/38) |
1.5–1.9 cm | n = 25 cases | 92.0%* | (23/25) |
pT2 (2.0–3.9 cm) | n = 44 cases | 97.7%* | (43/44) |
2.0–2.9 cm | n = 30 cases | 100% | (30/30) |
3.0–3.9 cm | n = 14 cases | 92.9%* | (13/14) |
pT3 (= 4 cm) | n = 21 cases | 85.7%* | (18/21) |
pT4 (any size, extend beyond thyroid capsule) | n = 16 cases | 93.8%* | (15/16) |